| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 08/11/2022 | Pyxis Oncology, Inc. | PYXS | Grant | Stock Option (Right to Buy) | 236.2k | $2.91 | $687.4k | | 08/11/2022 |
| 02/17/2021 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 60k | $28.69 | $1.7M | | 02/17/2021 |
| 09/08/2020 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Stock Option (Right to Buy) | 150k | $28.14 | $4.2M | | 09/08/2020 |
| 09/08/2020 | Black Diamond Therapeutics, Inc. | BDTX | Grant | Common Stock | 10k | $0.00 | $0 | | 09/08/2020 |
| 01/25/2019 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (right to buy) | 90k | $16.85 | $1.5M | | 01/25/2019 |
| 03/02/2018 | CytomX Therapeutics, Inc. | CTMX | Exercise | Stock Option (Right to Buy) | 16.2k | $6.61 | $106.9k | | 03/02/2018 |
| 03/02/2018 | CytomX Therapeutics, Inc. | CTMX | Sale | Common Stock | 16.2k | $30.00 | $484.8k | | 03/02/2018 |
| 02/28/2018 | CytomX Therapeutics, Inc. | CTMX | Exercise | Stock Option (Right to Buy) | 23.8k | $6.61 | $157.7k | | 02/28/2018 |
| 02/28/2018 | CytomX Therapeutics, Inc. | CTMX | Sale | Common Stock | 23.8k | $30.00 | $715.2k | | 02/28/2018 |
| 01/24/2018 | CytomX Therapeutics, Inc. | CTMX | Grant | Stock Option (right to buy) | 100k | $25.82 | $2.6M | | 01/24/2018 |
| 12/15/2017 | CytomX Therapeutics, Inc. | CTMX | Exercise | Stock Option (Right to Buy) | 15.1k | $6.61 | $100k | | 12/15/2017 |
| 12/28/2016 | CytomX Therapeutics, Inc. | CTMX | Exercise | Stock Option (Right to Buy) | 15.1k | $6.61 | $100k | | 12/28/2016 |